Activest Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Activest Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.09K	Hold	74	–	–	﹤0.01%	623
2026 Q1	$7.69K	Hold	74	–	–	﹤0.01%	740
2025 Q4	$7.63K	Hold	74	–	–	﹤0.01%	711
2025 Q3	$6.69K	Hold	74	–	–	﹤0.01%	590
2025 Q2	$6.51K	Hold	74	–	–	﹤0.01%	511
2025 Q1	$6.74K	Sell	74 -299	-80%	-$26.9K	﹤0.01%	466
2024 Q4	$32.2K	Buy	+373	New	+$33.7K	0.01%	211
2023 Q1	–	Sell	-880	Closed	-$70.1K	–	495
2022 Q4	$70.1K	Buy	+880	New	+$64.9K	0.02%	163

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Activest Wealth Management's PPH Position: Q2 2026 in Review

Activest Wealth Management held its VanEck Pharmaceutical ETF (PPH) position steady in Q2 2026 at 74 shares worth $8.09K. The position accounts for ﹤0.01% of the portfolio, ranked #623.

Activest Wealth Management first reported a position in PPH in Q4 2022 and has held it in 8 quarters since. The position peaked at $70.1K in Q4 2022. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Activest Wealth Management held 74 shares of VanEck Pharmaceutical ETF worth $8.09K as of Q2 2026.
Activest Wealth Management left its VanEck Pharmaceutical ETF share count unchanged in Q2 2026.
VanEck Pharmaceutical ETF made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #623 holding.
Activest Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and has held it in 8 quarters since.
Activest Wealth Management's VanEck Pharmaceutical ETF position peaked at $70.1K in Q4 2022.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.